# Isoniazid + Pyrazinamide + Rifampicin

## RifaTER 80/250/120mg (複方)

| 藥物代碼           | ORIFA                                                                                                                                                                                                                                               |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Initial intensive phase treatment (usually 2 months) for short course chemotherapy of TB. When indicated other anti-TB drugs may be added. After the intensive phase treatment, therapy should be continue with Rifinah for a further 4 months min. |
| 副作用             | Staining of contact lenses, reddish coloration of urine, sputum & lachrymal fluid. Irregular dosing may result in immunological side effects eg 'flu syndrome'.                                                                                     |
| 禁忌               | Hypersensitivity; presence of jaundice.                                                                                                                                                                                                             |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                      |
| 孕期用藥建議       | Compatible - maternal benefit >> embryo-fetal risk                                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                 |
| 附帶說明           | N/A                                                                                                                                                                                                                                                 |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                 |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                 |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                 |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                 |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                 |
| 注意事項           | N/A                                                                                                                                                                                                                                                 |

